Thermo Fisher Scientific Reports Record 2007 Fourth Quarter Revenues and Operating Performance; Provides Guidanc...( preceding items and other tax eve...)

preceding items and other tax events (see note (h) for details); and

results of discontinued operations.

(c) Reported results in 2007 include $1.2 primarily for charges for the

sale of inventories revalued at the date of acquisition. Reported

results in 2006 include $74.1 of charges for the sale of inventories

revalued at the date of acquisition and $0.3 of accelerated

depreciation on manufacturing assets abandoned due to facility

consolidations.

(d) Reported results in 2007 and 2006 include restructuring and other

costs, net, consisting principally of severance, abandoned facility

and other expenses of real estate consolidation, net of

net gains in 2006 on the sale of product lines and abandoned

facilities. Reported results in 2006 also include $15.2 of charges for

in-process research and development associated with the

Fisher merger.

(e) Reported results in 2006 include a charge for the acceleration of

equity-based compensation expense due to a change in control.

(f) Reported results in 2006 include $0.9 of cost associated with the

early termination of debt/credit facilities in interest expense.

(g) Reported results in 2007 included an $8.9 loss from an other than

temporary decline in the fair market value of an available-for-sale

investment and a $4.5 currency transaction gain associated with an

intercompany financing transaction.

(h) Reported provision for income taxes includes i) $62.2 and $80.6 of

incremental tax benefit in 2007 and 2006, respectively, for the pre-

tax reconciling items between GAAP and adjusted net

income; and ii) in 2007, $11.1 of incremental tax benefit from

adjusting the company's deferred tax balances as a result of newly

enacted tax rates, primarily in Canada.

(i) Cons
'/>"/>